Allergies & Asthma

Among patients with chronic obstructive pulmonary disease (COPD) and severe chronic breathlessness, short-term daily treatment with low doses of extended-release morphine did not significantly reduce the intensity of worst breathlessness, a randomized trial showed. At 1 week, change in the intensity of worst breathlessness was not significantly different between patients who received 8 mg/day of
0 Comments
LOUISVILLE, Ky. — Treatment with add-on dupilumab (Dupixent) was linked with clinically meaningful improvements in hives and itch severity in patients with chronic spontaneous urticaria (CSU), according to the LIBERTY-CSU CUPID Study A trial. In patients as young as 6 years with itch and hives that were not adequately controlled on antihistamine treatment alone, dupilumab
0 Comments
LOUISVILLE, Ky. — A sublingual film may be able to deliver epinephrine as effectively as intramuscular injections and provide an alternate pathway for urgent treatment of allergic anaphylaxis, a researcher suggested here. In testing with healthy volunteers, the sublingual film loaded with AQST-109, which delivers 12 mg of epinephrine, appeared to have similar pharmacokinetics as
0 Comments
LOUISVILLE, Ky. — An investigational fixed-dose combination of a short-acting beta2-adrenergic agonist and an inhaled corticosteroid appeared to slow the deterioration in lung function and reduce severe exacerbations for patients with mild-to-moderate asthma, according to an exploratory analysis of a phase III trial. Among the nearly 1,000 patients in the DENALI trial, those in the
0 Comments
LOUISVILLE, Ky. — An accelerated form of intradermal skin testing (IDT) was found feasible and safe in patients with suspected allergies to hymenoptera venom, such as those from bee and wasp stings, researchers stated. In a retrospective study comparing adverse events (AEs) in patients who underwent standard and accelerated flying hymenoptera venom IDT, none of
0 Comments
Health insurance can get confusing, especially during the federal Health Insurance Marketplace’s (Healthcare.gov) open enrollment period each year. Here are some things to know about health care for 2023. What Is Open Enrollment? Open enrollment refers to the time period when you can add or change your health insurance. Outside of that time frame, you
0 Comments
For the most part, everyone knows the feeling of being tired. Sleep deprivation is a serious issue that can lead to health complications like weight gain, weakened immunity, irritability, and even heart disease. Allergies and their corresponding symptoms such as coughing, sneezing, headaches, and nasal congestion can cause someone to lose hours of valuable sleep.
0 Comments
The FDA’s Pulmonary-Allergy Drugs Advisory Committee on Tuesday will consider whether a novel two-drug combination inhaler for asthma should be the first FDA-approved product containing an inhaled corticosteroid (budesonide) and a short-acting beta2-adrenergic agonist (albuterol sulfate). Also novel is the proposed indication of preventing severe exacerbations, and the use of an inhaled corticosteroid-containing product as
0 Comments
Millions of Americans suffer from spring and fall allergies every year. Many haven’t considered the area they live in and how it contributes to their allergy symptoms. The AAFA’s yearly Allergy Capitals™ report identifies which cities are the most challenging to live in with seasonal allergies. The report considers these factors: Spring pollen scores Fall
0 Comments
A national study recently found that Black and Hispanic children are at a higher risk than white children for developing asthma across all neighborhoods. The study is titled, “Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium.”  Many factors may play a role in this higher risk. Children of
0 Comments
NASHVILLE, Tenn. — Treatment with the biologic dupilumab (Dupixent) was associated with sustained reductions in oral corticosteroid (OCS) use in asthma patients who required both low and high daily OCS doses at baseline, according to post hoc findings from the open-label, extension LIBERTY ASTHMA TRAVERSE trial. Further follow-up of patients in the study also showed
0 Comments
NASHVILLE, Tenn. — Racial biases persist in the use of pulse oximetry devices for patients with acute hypoxemic respiratory failure (AHRF) requiring very high levels of oxygen support, a retrospective analysis suggested. In comparing direct arterial blood gas readings versus pulse oximetry readings among patients at a single intensive care unit (ICU), Black patients had
0 Comments
Subcutaneous immunotherapy treatment (SCIT) for reducing cat allergy symptoms appeared to be more effective and longer lasting with the help of tezepelumab (Tezspire), a monoclonal antibody recently approved for severe asthma, results from a phase I/II trial suggested. While the randomized CATNIP trial failed to meet its primary endpoint — a difference in total nasal
0 Comments
Antihistamines were involved in at least 15% of recent overdose deaths, according to 2019-2020 data from 43 states and the District of Columbia. Of 92,033 overdose deaths during this time period, 14.7% were antihistamine-positive and 3.6% were antihistamine-involved, reported Amanda Dinwiddie, MPH, of the CDC’s National Center for Injury Prevention and Control in Atlanta, and
0 Comments
It is a very sad state of affairs when nurses are being pushed to their limit, having given their all to save lives and are not rewarded for their dedication especially after the few years where many chose to sacrifice being with the family to protect them while they went off to look after those
0 Comments
Everyone has experienced stress at some point, but what is it? Stress is your body’s reaction to a threat or challenge. We generally think of stress as being caused by a negative situation like an overly hectic day at work or death of a loved one, but it can also be caused by positive events
0 Comments